Abbott's Cardio-Focused $25B Deal Could Raise FTC's Pulse
Abbott Laboratories has touted its proposed $25 billion acquisition of medical device maker St. Jude Medical as a chance to combine the companies' cardiovascular device offerings, but any overlap in that...To view the full article, register now.
Already a subscriber? Click here to view full article